2. Search Result
Search Result
Results for "

D-arabinose-<sup>13</sup>C-2

" in MedChemExpress (MCE) Product Catalog:

2105

Inhibitors & Agonists

6

Fluorescent Dye

24

Biochemical Assay Reagents

22

Peptides

6

Inhibitory Antibodies

66

Natural
Products

40

Recombinant Proteins

1422

Isotope-Labeled Compounds

27

Antibodies

68

Click Chemistry

47

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N0059
    D-Arabinose

    		Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) [2] .
    D-Arabinose
  • HY-N0059R
    D-Arabinose (Standard)

    		Reference Standards Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose (Standard) is the analytical standard of D-Arabinose. This product is intended for research and analytical applications. D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) [2] .
    D-Arabinose (Standard)
  • HY-W746880
    D-Arabinose Phenylhydrazone-13C5

    		Isotope-Labeled Compounds Others
    D-Arabinose Phenylhydrazone- 13C5 is the 13C-labeled D-Arabinose Phenylhydrazone.
    D-Arabinose Phenylhydrazone-13C5
  • HY-N0059S2
    D-arabinose-13C-2

    		Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose- 13C-2 is the 13C labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) [2] .
    D-arabinose-13C-2
  • HY-167291
    D-Arabinose 5-phosphate sodium

    		Biochemical Assay Reagents Others
    D-Arabinose 5-phosphate (sodium) is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology, and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to basic research, biomedicine, and biotechnology .
    D-Arabinose 5-phosphate sodium
  • HY-N0059S4
    D-Arabinose-d2

    		Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose-d2 is the deuterium labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) [2] .
    D-Arabinose-d2
  • HY-N0059S
    D-Arabinose-13C

    		Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose- 13C is the 13C labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) [2] .
    D-Arabinose-13C
  • HY-N0059S6
    D-Arabinose-d6

    		Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose-d6 is the deuterium labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) [2] .
    D-Arabinose-d6
  • HY-N0059S5
    D-Arabinose-d5

    		Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose-d5 is the deuterium labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) [2] .
    D-Arabinose-d5
  • HY-N0059S1
    D-Arabinose-13C-1

    		Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose- 13C-1 is the 13C labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) [2] .
    D-Arabinose-13C-1
  • HY-N0059S3
    D-Arabinose-13C-3

    		Isotope-Labeled Compounds Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinose- 13C-3 is the 13C labeled D-Arabinose (HY-N0059). D-Arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-Arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-Arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-Arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-Arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) [2] .
    D-Arabinose-13C-3
  • HY-W590664
    C2 Dihydroceramide

    		Endogenous Metabolite Cardiovascular Disease
    C2 Dihydroceramide is a derivative of C2 Ceramide (HY-101180). C2 Dihydroceramide enhances the ABCA1-mediated cholesterol efflux to apolipoprotein A-I (apoA-I) without causing cytotoxicity .
    C2 Dihydroceramide
  • HY-138083
    Parvodicin C2

    		Bacterial Antibiotic Infection
    Parvodicin C2 is a glycopeptide antibiotic that can be isolated from parvosata. Parvodicin C2 has antibacterial activity .
    Parvodicin C2
  • HY-N1517
    Ganoderic acid C2

    		Aldose Reductase Inflammation/Immunology Cancer
    Ganoderic acid C2 is a bioactive triterpenoid in Ganoderma lucidum. Ganoderic acid C2 possesses the potential anti-tumor bioactivity, antihistamine, anti-aging and cytotoxic effects. Ganoderic acid C2 is the inhibitor for aldose reductase with an IC50 of 43.8 µM [2].
    Ganoderic acid C2
  • HY-N1517R
    Ganoderic acid C2 (Standard)

    		Aldose Reductase Reference Standards Inflammation/Immunology Cancer
    Ganoderic acid C2 (Standard) is the analytical standard of Ganoderic acid C2. This product is intended for research and analytical applications. Ganoderic acid C2 is a bioactive triterpenoid in Ganoderma lucidum. Ganoderic acid C2 possesses the potential anti-tumor bioactivity, antihistamine, anti-aging and cytotoxic effects. Ganoderic acid C2 is the inhibitor for aldose reductase with an IC50 of 43.8 µM [2].
    Ganoderic acid C2 (Standard)
  • HY-N1517A
    (Rac)-Ganoderic acid C2

    		Aldose Reductase Cancer
    (Rac)-Ganoderic acid C2 is the racemate of Ganoderic acid C2 (HY-N1517). Ganoderic acid C2 is a bioactive triterpenoid in Ganoderma lucidum. Ganoderic acid C2 possesses anti-tumor, antihistamine, anti-aging and cytotoxic effects. Ganoderic acid C2 exhibits high inhibitory activity against the rat lens aldose reductase (RLAR) with an IC50 of 3.8 µM[ [2].
    (Rac)-Ganoderic acid C2
  • HY-N14459
    Pluracidomycin C2

    		Antibiotic Bacterial Infection
    Pluracidomycin C2 is a carbapenem antibiotic. Pluracidomycin C2 has anti-Gram-positive bacteria and Gram-negative bacteria activities .
    Pluracidomycin C2
  • HY-N12297
    Ciwujianoside C2

    		Lipase Others
    Ciwujianoside C2 is a saponin, that can be isolated from the leaves of Acanthopanax senticosus. Ciwujianoside C2 enhances pancreatic lipase activity in vitro .
    Ciwujianoside C2
  • HY-N7521
    Procyanidin C2

    Procyanidine C2

    		 Others Others
    Procyanidin C2 is a phenol glycoside derived from Fagopyrum dibotrys (D. Don) Hara .
    Procyanidin C2
  • HY-N15704
    Cassiaside C2

    		Histamine Receptor Inflammation/Immunology
    Cassiaside C2 is a naphthopyrone with a strong antiallergic activity. Cassiaside C2 inhibits the histamine release from rat peritoneal exudate mast cells induced by antigen-antibody reaction [2].
    Cassiaside C2
  • HY-N14431
    Salfredin C2

    		Aldose Reductase Metabolic Disease
    Salfredin C2 is an aldose reductase inhibitor .
    Salfredin C2
  • HY-N11857
    Gentamicin C2

    		Antibiotic Bacterial Infection
    Gentamicin C2 is an aminoglycoside antibiotic .
    Gentamicin C2
  • HY-W777012
    Acridinium C2 NHS ester

    		Fluorescent Dye
    Acridinium C2 NHS ester is a chemiluminescent label that is active for the development of protein and nucleic acid probes. Acridinium C2 NHS ester can be used in bioanalysis and diagnostics to provide highly sensitive detection solutions. Acridinium C2 NHS ester is widely used in medical research, especially in the monitoring and analysis of biomolecules.
    Acridinium C2 NHS ester
  • HY-126830
    Antifolate C2

    		Antifolate Apoptosis Cancer
    Antifolate C2 is an anti-folate compound that has inhibitory effects on the proliferation of non-squamous non-small cell lung cancer (NS-NSCLC). Antifolate C2 achieves tumor selectivity by targeting proton-coupled folate transporter (PCFT), which is more selective to PCFT than the commonly used anti-folate drug Pemetrexed (HY-10820). Antifolate C2 blocks the biosynthesis of deoxypurine nucleotides by inhibiting glycinamide ribonucleotide formyltransferase (GARFTase), ultimately inhibiting the proliferation of tumor cells. Antifolate C2 can be used in studies of NS-NSCLC, especially in patients who do not respond well to Pemetrexed .
    Antifolate C2
  • HY-N14844
    Napyradiomycin C2

    		Antibiotic Bacterial Infection
    Napyradiomycin C2 is an antibiotic with anti-Gram-positive bacteria and mycobacterial activity .
    Napyradiomycin C2
  • HY-NP202
    C2 Protein (human)

    		Complement System Inflammation/Immunology
    C2 Protein (human) is a naturally glycosylated peptide with a 20 amino acid signal sequence. Complement component C2 functions as a key regulator in the early activation phase of the classical pathway and participates in the formation of the classical pathway C3 convertase C4b2a .
    C2 Protein (human)
  • HY-165072
    C2 3'-Sulfo galactosylceramide (d18:1/2:0)

    C2 Sulfatide; N-Acetyl sulfatide

    		 Others Others
    C2 3'-Sulfo galactosylceramide (d18:1/2:0) (C2 Sulfatide) is one of the sulfatide class of glycolipids. C2 3'-Sulfo galactosylceramide (d18:1/2:0) can be used in the quantification of lysosulfatides in mouse brain tissue and plasma .
    C2 3'-Sulfo galactosylceramide (d18:1/2:0)
  • HY-N5199
    4"-Demethylgentamicin C2

    		Bacterial Infection
    4"-Demethylgentamicin C2 has anti-Gram-positive and negative bacteria activity .
    4
  • HY-130155
    AMPK activator C2

    		AMPK Neurological Disease
    AMPK activator C2 is a potent allosteric AMPK activator that is promising for research of epilepsy and convulsions .
    AMPK activator C2
  • HY-W590667
    C2 Ceramide-1-phosphate

    		Biochemical Assay Reagents Others
    C2 Ceramide-1-phosphate is a phospholipid. Phospholipids have good biocompatibility and significant amphiphilic characteristics, making them the main and suitable dosage form or excipient in drug formulations, thereby achieving better therapeutic effects. C2 Ceramide-1-phosphatecan be used in drug delivery research .
    C2 Ceramide-1-phosphate
  • HY-N14705
    2-Hydroxygentamicin C2

    		Antibiotic Bacterial Infection
    2-Hydroxygentamicin C2 is an antibiotic of the gentamicin group with anti-Gram-positive and negative bacteria activity .
    2-Hydroxygentamicin C2
  • HY-101180
    C2 Ceramide
    2 Publications Verification

    Ceramide 2

    		 Phosphatase Mitochondrial Metabolism Apoptosis Autophagy Metabolic Disease Endocrinology
    C2 Ceramide (Ceramide 2) is the main lipid of the stratum corneum and a protein phosphatase 1 (PP1) activator. C2 Ceramide activates PP2A and ceramide-activated protein phosphatase (CAPP). C2 Ceramide induces cells differentiation, autophagy and apoptosis, inhibits mitochondrial respiratory chain complex III. C2 Ceramide is also a skin conditioning agent that protects the epidermal barrier from water loss [2] .
    C2 Ceramide
  • HY-N14104
    Cinatrin C2

    		Phospholipase Others
    Cinatrin C2 is a phospholipase A2 (PLA2) inhibitor with an IC50 of 800 μM and can be extracted from Circinotrichum falcatisporum RF-641 [2].
    Cinatrin C2
  • HY-N14709
    Kibdelin C2

    		Bacterial Infection
    Kibdelin C2 is resistant to Gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as Vancomycin (HY-B0671) .
    Kibdelin C2
  • HY-N6910
    Pseudolaric Acid C2

    		Others Metabolic Disease
    Pseudolaric Acid C2, a diterpenoid isolated from Pseudolarix kaempferi, is identified as the specific metabolite of Pseudolaric acid B in plasma, urine, bile and feces after both oral and intravenous administration to rats [2].
    Pseudolaric Acid C2
  • HY-169480
    Lipid C2

    		Liposome Infection Cancer
    Lipid C2 is an ionizable cationic lipid that has been used in the formation of lipid nanoparticles (LNP) for mRNA delivery in vivo. LNPs containing Lipid C2 and encapsulating an mRNA reporter selectively accumulate in the liver and spleen but not the heart, lungs, or kidneys in mice. LNP containing Lipid C2 and encapsulating mRNA encoding the Epstein-Barr virus (EBV) protein latent membrane protein 2 (LMP-2), in combination with an anti-programmed cell death protein 1 (PD-1) antibody, decrease tumor volume and reverse T cell exhaustion, as well as increase the percentage of CD3 +CD8 + central and CD3 +CD8 + effector memory T cells and decrease the percentage of CD3 + T cells expressing Pd-1, in the spleen in a CT26 murine EBV-infected colon cancer model .
    Lipid C2
  • HY-RS17030
    C2 Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    C2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for C2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    C2 Mouse Pre-designed siRNA Set A
    C2 Mouse Pre-designed siRNA Set A
  • HY-RS23474
    C2 Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    C2 Rat Pre-designed siRNA Set A contains three designed siRNAs for C2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    C2 Rat Pre-designed siRNA Set A
    C2 Rat Pre-designed siRNA Set A
  • HY-RS01738
    C2 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    C2 Human Pre-designed siRNA Set A contains three designed siRNAs for C2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    C2 Human Pre-designed siRNA Set A
    C2 Human Pre-designed siRNA Set A
  • HY-135868
    Mito-apocynin (C2)

    		Mitochondrial Metabolism Neurological Disease
    Mito-apocynin (C2), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP + cation. Mito-apocynin (C2) exhibits antineuroinflammatory effect .
    Mito-apocynin (C2)
  • HY-166226
    C2 Sphingomyelin (d18:1/2:0)

    		Biochemical Assay Reagents Metabolic Disease
    C2 Sphingomyelin (d18:1/2:0) is an ester product.
    C2 Sphingomyelin (d18:1/2:0)
  • HY-B0141S7
    rel-Estradiol-13C6

    		Isotope-Labeled Compounds Others
    rel-Estradiol- 13C6 is the sup>13C-labeled rel-Estradiol .
    rel-Estradiol-13C6
  • HY-N7082
    D-Arabinopyranose

    		Parasite Bacterial AMPK PPAR Infection Neurological Disease Metabolic Disease
    D-Arabinopyranose is a rare aldehyde pentose, and its ring-opened form is D-arabinose (HY-N0059). D-arabinose is is an orally active antidepressant and a growth inhibitor of C. elegans (IC50 is 7.5 mM). D-arabinose can penetrate the blood-brain barrier, selectively interfere with the metabolism of D-ribose and D-fructose, and inhibit the growth of nematodes. D-arabinose can also inhibit the synthesis of cell biofilm and exert antibacterial activity. D-arabinose activates the ACSS2-PPARγ/TFEB-CRTC1 axis through the lysosomal AXIN-LKB1-AMPK pathway, inducing CRTC1 transcription, exerts antidepressant-like activity. D-arabinose is the ring-opened form of the aldopentose D-?Arabinose (HY-N7082) [2] .
    D-Arabinopyranose
  • HY-Y0418S2
    Dulcite-13C-2

    Dulcitol-<sup>13sup>C-2; Melampyrit-<sup>13sup>C-2; NSC 1944-<sup>13sup>C-2

    		 Isotope-Labeled Compounds Endogenous Metabolite Others
    Dulcite- 13C-2 is the 13C labeled Dulcite. Dulcite is a sugar alcohol with a slightly sweet taste which is a metabolic breakdown product of galact [2].
    Dulcite-13C-2
  • HY-N15125
    1-Deamino-1-hydroxygentamicin C2

    Antibiotic SU-1

    		 Antibiotic Bacterial Infection
    1-Deamino-1-hydroxygentamicin C2 (Antibiotic SU-1) is an aminoglycotone antibiotic. 1-Deamino-1-hydroxygentamicin C2 has the activity against Gram-positive and Gram-negative bacteria .
    1-Deamino-1-hydroxygentamicin C2
  • HY-116877
    C2 Ceramide (d14:1/2:0)

    		COX Cancer
    C2 Ceramide (d14:1/2:0) is a composition for diagnosing diseases associated with cyclooxygenase 2 (COX2) overexpression. C2 Ceramide (d14:1/2:0) exhibits a strong binding activity to COX2 protein (extracted from patent WO2019235824A1).
    C2 Ceramide (d14:1/2:0)
  • HY-N6980
    Licorice glycoside C2
    1 Publications Verification

    		 HIV Infection Cancer
    Licorice glycoside C2 is a oleanane-type triterpene oligoglycoside isolated from Glycyrrhiza uralensis. Various biological activities are associated with licorice extracts, such as anti-viral, anti-microbial, antioxidant, anti-inflammatory, anti-ulcer, anti-cancer and anti-HIV effects .
    Licorice glycoside C2
  • HY-131992
    N-Acetylpsychosine

    C2 Galactosylceramide (d18:1/2:0)

    		 Apoptosis Inflammation/Immunology
    N-Acetylpsychosine (C2 Galactosylceramide (d18:1/2:0)), α-galactosylated C2-ceramide, has immunostimulatory activity. N-Acetylpsychosine can be a useful tool to investigate the mechanism of apoptosis and the immune reponses induced by dendritic cells (DCs) .
    N-Acetylpsychosine
  • HY-W338294S1
    2'-Deoxycytidine-13C-2 monohydrate

    Deoxycytidine-<sup>13sup>C-2 monohydrate; Cytosine deoxyriboside-<sup>13sup>C-2 monohydrate; Deoxyribose cytidine-<sup>13sup>C-2 monohydrate

    		 Isotope-Labeled Compounds Endogenous Metabolite Others
    2'-Deoxycytidine- 13C-2 (monohydrate) Monohydrate is the 13C labeled 2'-Deoxycytidine .
    2'-Deoxycytidine-13C-2 monohydrate
  • HY-156207
    C2 Adamantanyl globotriaosylceramide (d18:1/2:0)

    AdaGb3; Adamantyl Gb3; C2 Adamantanyl Ceramide Trihexoside (d18:1/2:0)

    		 P-glycoprotein Cancer
    C2 Adamantanyl globotriaosylceramide (d18:1/2:0) (AdaGb3), a water-soluble globotriaosylceramide analog, is a bioactive sphingolipid. C2 Adamantanyl globotriaosylceramide (d18:1/2:0) reverses MDR1-MDCK cell drug resistance. C2 Adamantanyl globotriaosylceramide (d18:1/2:0) has high affinity for verotoxin (VT) [2].
    C2 Adamantanyl globotriaosylceramide (d18:1/2:0)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: